glyburide and lornoxicam

glyburide has been researched along with lornoxicam in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Johnston, A; Ravic, M; Turner, P1
Chen, XY; Guo, YJ; Si, DY; Zhang, YF; Zhong, DF; Zhou, H1

Reviews

1 review(s) available for glyburide and lornoxicam

ArticleYear
Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs.
    Postgraduate medical journal, 1990, Volume: 66 Suppl 4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Digoxin; Drug Interactions; Furosemide; Glyburide; Humans; Male; Piroxicam; Warfarin

1990

Other Studies

4 other study(ies) available for glyburide and lornoxicam

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
[Impact of cytochrome P450 CYP2C9 variant allele CYP2C9 * 3 on the pharmacokinetics of glibenclamide and lornoxicam in Chinese subjects].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2005, Volume: 40, Issue:9

    Topics: Adult; Alleles; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Asian People; China; Cytochrome P-450 CYP2C9; Genotype; Glyburide; Humans; Hypoglycemic Agents; Male; Piroxicam; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length

2005